Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03125278 · ClinicalTrials.gov registry record

Patient Knowledge of Medication Indication

A clinical trial, sponsored by HealthPartners Institute.

Completed
Registry status
40
Enrollment target

NCT03125278: Completed study, sponsored by HealthPartners Institute.

NCT03125278 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03125278 has completed, sponsored by HealthPartners Institute.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

This is a study to compare patient knowledge about the indications of their medications between two sites. Regions Hospital has a population of patients that receive the medication indication on the label for any new or changed medications at the time of patient discharge. Brigham Women's Health follows a standard policy of discharge medication labels including the name of the medication and instructions for use without any indication of what the medication is intended to treat. Consented patient will receive a phone call where researchers will ask about which medications they are taking and other questions about those medications. The study population will be patients recently discharged from the hospital with 1 or more new or changed medications

Primary Outcome

Scripted questionnaire administered on patients knowledge of their medication indications who received new, changed, or continued medications at discharge via phone call. Questions are focused on understand of relationship of the medication and what symptom or disease it is teaching.

Interventions

  • OTHER Medication knowledge

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-04-11
Est. Completion 2017-10-31
HealthPartners Institute

146 total trials

What the finished NCT03125278 record still lists

NCT03125278 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Medication knowledge is the first listed.

NCT03125278 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03125278 about?

NCT03125278 is a clinical study titled "Patient Knowledge of Medication Indication". This is a study to compare patient knowledge about the indications of their medications between two sites. Regions Hospital has a population of patients that receive the medication indication on the label for any new or changed medications at the time of patient discharge. Brigham Women's Health fol...

What is the current status of trial NCT03125278?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-04-11. Estimated completion is 2017-10-31.

What interventions are being tested in trial NCT03125278?

The interventions under investigation include: Medication knowledge (OTHER).

Who is sponsoring clinical trial NCT03125278?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03125278, the US trial registry maintained by the National Library of Medicine. NCT03125278 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.